
Commentary|Podcasts|June 21, 2024
Navigating Market Access Hurdles
Mark Bouck discusses PharmAlliance’s latest acquisitions, while reiterating its goals surrounding health economics and outcomes research.
Advertisement
In this exclusive PC Podcast interview, Mark Bouck, chairman and CEO of PharmAlliance, a pharmaceutical and life sciences services platform, dives into:
- How PharmAlliance’s acquisition of Complete Health Economics Outcomes Research Solutions (CHEORS) helps expand global reach
- The platform’s biggest goal to when it comes to CHEORS and market access services
- How CHEORS helps navigate cost-effectiveness and market access hurdles
- Acquisitions in the space that are currently in the works
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Samsung Biologics Enters US Manufacturing Market with $280M GSK Site Acquisition
2
Pharma Pulse: TrumpRx Gains Nine New Pharma Partners; DHL Expands LAX Cold Chain Hub
3
Trade & Channel Strategies 2025: Waiting, Watching, and Reshoring
4
President Trump Announces Nine More TrumpRx Participants
5




